Program Eliminasi Lymphatic Filariasis di Indonesia

Gusti Meliyanie, Dicky Andiarsa

Abstract


Filariasis telah menjadi masalah kesehatan masyarakat di Indonesia sejak lama dan WHO telah menetapkan penyakit ini sebagai penyakit yang terabaikan dan menjadi masalah kesehatan masyarakat di dunia, untuk itu dicanangkan program Eliminasi filariasis secara global dengan target eliminasi pada tahun 2020. Artikel ini menghimpun 44 literatur sebagai bahan utama penulisan terkait perkembangan eliminasi filariasis global secara umum dan kemajuan eliminasi filariasis di Indonesia khususnya. Program eliminasi filariasis di Indonesia sudah berjalan setidaknya ada 51 kabupaten yang telah berhenti melaksanakan POPM dari 236 kabupaten yang endemis filariasis. Kabupaten tersisa diharapkan sudah melaksanakan POPM sejak 2015 sehingga tahun 2020 selesai dan dilakukan verifikasi dan diberikan predikat eliminasi filariasis sesuai target global eliminasi filariasis. Penelitian berbasis manajemen dan komunitas penting dilakukan untuk menentukan model terbaik dalam eliminasi. Masih banyak tantangan dalam meningkatkan cakupan, karenanya upaya edukasi berkelanjutan tentang filariasis dan pentingnya pengobatan akan menggerakkan masyarakat untuk berperan aktif dalam pencapaian target cakupan secara maksimal, dan target eliminasi filariasis nasional dapat tercapai di tahun 2020.

 


References


World Health Organization (WHO), Global Programme to Eliminate. Monitoring and Epidemiological Assessment of Mass Drug Administration: Lymphatic Filariasis, Manual for National Elimination Programmes. World Health Organization; 2011.

Balitbangkes. Pedoman pengumpulan data studi model pengembangan eliminasi filariasis. Jakarta: Puslitbang Upaya Kesehatan Masyarakat, Balitbangkes, Kemenkes RI; 2017.

Wibawa T, Baskoro T, Satoto T. Magnitude of Neglected Tropical Diseases in Indonesia at Postmillennium Development Goals Era. J Trop Med. 2016;2016(Article ID 5716785):1–9.

Masrizal. Penyakit filariasis. J Kesehat Masy. 2013;7(1):32–8.

Supali T. Keberhasilan program eliminasi filariasis di Kabupaten Alor, Nusa Tenggara Timur. Buletin Jendela Epidemiologi. 2010;1(Juli):20–3.

Ditjen PP & PL. Pedoman Program Eliminasi Filariasis di Indonesia. Jakarta: Ditjen PP & PL, Depkes RI; 2009.

Pusdatin. Situasi filariasis di Indonesia tahun 2015. Infodatin. 2016;8.

Otsuji Y. History , Epidemiology and Control of Filariasis. Trop Med Health. 2011;39(1, supplement 02):3–13.

De-jian S, Xu-li D, Ji-hui D. The history of the elimination of lymphatic filariasis in China. Infect Dis Poverty. 2013;2(1):30.

Arsin AA. Epidemiologi Filariasis. 1st ed. Makassar: Masagena Press Makassar; 2016. 126 p.

David HL, Edeson JF. Filariasis in Portuguese Timor, with observations on a new microfilaria found in man. Ann Trop Med Parasitol. 1965;59:193–204.

Paily KP, Hoti SL, Das KP. A review of the complexity of biology of lymphatic fi larial parasites. J Parasit Dis. 2009;33(1&2):3–12.

Partono F, Aennis DT, Atmosoedjono S, Oemijati S, J.H. Cross. Brugia timori sp.n. (Nematoda: Filarioidea) from Flores Island, Indonesia. J Parasitol. 1977;63(3):540–6.

Chavatte J, Jureen R. Imported Asymptomatic Bancroftian Filariasis Discovered from a Plasmodium vivax Infected Patient: A Case Report from Singapore. Vol. 2017, Hindawi Infectious Diseases. Hindawi; 2017. p. 1–8.

Sudomo M, Hanifah A, Mak J, Lim B. A study of malayan filariasis in Lubuk Mumpo and Datar Lebar villages in Lais Regency, North Bengkulu, Sumatera, Indonesia. Southeast Asian J Trop Med Public Heal. 1982;13(4):584–9.

Elytha F. Transmission assessment survey sebagai salah satu langkah penentuan eliminasi filariasis. J Kesehat Masy Andalas. 2014;8(2):85–92.

Ditjen PP & PL. Rencana aksi program pengendalian penyakit dan penyehatan lingkungan. Jakarta: Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan, Kemenkes RI; 2015. 59 p.

Kemenkes RI. Menkes hadiri puncak BELKAGA DI Gunung Mas. Halo Kemkes [Internet]. 2016; Available from: http://www.depkes.go.id/article/print/16100500002/menkes-hadiri-puncak-belkaga-di-gunung-mas.html

Addiss D. The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases. Parasit Vectors. 2010;3(1):100.

Astuti EP, Ipa M, Wahono T, Ruliansyah A. Analisis perilaku masyarakat terhadap kepatuhan minum obat filariasis di tiga desa Kecamatan Majalaya Kabupaten Bandung Tahun 2013. Media Litbang Kesehat. 2014;24(4):199–208.

Ipa M, Astuti EP, Hakim L, Fuadzy H. Analisis Cakupan Obat Massal Pencegahan Filariasis di Kabupaten Bandung dengan Pendekatan Model Sistem Dinamik. BALABA. 2016;12(1):31–8.

Tuti S, Sismadi P, Ekowatiningsih R, Manumpil P. Situasi filariasis di pulau alor pada tahun 2006. BulPenelSistemKes. 2010;13(1):69–76.

Hotez PJ, Remme JHF, Buss P, Alleyne G, Morel C, Breman JG. Combating Tropical Infectious Diseases: Report of the Disease Control Priorities in Developing Countries Project. Clin Infect Dis. 2004;38(6):871–8.

Krentel A, Fischer PU, Weil GJ. A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis. PLoS Negl Trop Dis. 2013;7(11).

Njomo DW, Mukoko DA, Nyamongo NK, Karanja J. Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya. PLoS One. 2014;9(1):e83413.

Yimer M, Hailu T, Mulu W, Abera B. Epidemiology of elephantiasis with special emphasis on podoconiosis in ethiopia: A literature review. J Vector Borne Dis. 2015;52(2):111–5.

Goodwin NJ. Effects of participation and sense of community on change agents in an Indonesian sanitation behaviour change communications program. University of Sidney; 2016.

Bhullar N, Maikere J. Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia. Parasit Vectors. 2010;3(70):1–7.

Cano J, Rebollo MP, Golding N, Pullan RL, Crellen T, Soler A, et al. The global distribution and transmission limits of lymphatic filariasis: past and present. Parasit Vectors. 2014;7(466):1–19.

Jambulingam P, Subramanian S, de Vlas SJ, Vinubala C, Stolk WA. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators. Parasit Vectors. 2016;9(1):501.

Modi A, Gamit S, Jesalpura BS, Kurien G, Kosambiya JK. Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India. PLoS Negl Trop Dis. 2017;11(4):1–14.

Ojha CR, Joshi B, Kc KP, Dumre SP, Yogi KK, Bhatta B, et al. Impact of mass drug administration for elimination of lymphatic filariasis in Nepal. PLoS Negl Trop Dis. 2017;1–12.

Silumbwe A, Zulu JM, Halwindi H, Jacobs C, Zgambo J, Dambe R, et al. A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa. BMC Public Health. 2017;17(1):484.

Tambo E, Ai L, Zhou X, Chen J-H, Hu W, Bergquist R, et al. Surveillance-response systems: the key to elimination of tropical diseases. Infect Dis Poverty. 2014;3(1):17.

Wang J-L, Li T-T, Huang S-Y, Cong W, Zhu X-Q. Major parasitic diseases of poverty in mainland China: perspectives for better control. Infect Dis Poverty. 2016;5(1):67.

Bhumiratana A, Intarapuk A, Koyadun S, Maneekan P, Sorosjinda-nunthawarasilp P. Current Bancroftian Filariasis Elimination on Thailand-Myanmar Border: Public Health Challenges toward Postgenomic MDA Evaluation. ISRN Trop Med. 2013;2013(Article ID 857935):13 p.

Carme B. Rapid Assessment Procedure for Loiasis and Mapping Lymphatic Filariasis: Two Perfect Illustrations of “To Be in English or Not to Be.” PLoS Negl Trop Dis. 2012;6(12):1–4.

Chandra G. Nature limits filarial transmission. Parasit Vectors. 2008;1(1):13.

Ravindran R, Varghese S, Nair SN, Balan VM, Lakshmanan B, Ashruf RM, et al. Canine filarial infections in a human Brugia malayi endemic area of India. Biomed Res Int. 2014;2014.

Erickson SM, Thomsen EK, Keven JB, Vincent N, Koimbu G, Siba PM, et al. Mosquito-Parasite Interactions Can Shape Filariasis Transmission Dynamics and Impact Elimination Programs. PLoS Negl Trop Dis. 2013;7(9):1–7.

Mitjà O, Paru R, Hays R, Griffin L, Laban N, Samson M, et al. The impact of a filariasis control program on Lihir Island, Papua New Guinea. PLoS Negl Trop Dis. 2011;5(8):1–8.

Kyelem D, Biswas G, Bockarie MJ, Bradley MH, El-Setouhy M, Fischer PU, et al. Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. Am J Trop Med Hyg. 2008;79(4):480–4.

Carithers DS. Examining the role of macrolides and host immunity in combatting filarial parasites. Parasite Immunol. 2017;10(183):1–13.

Moreno Y, Nabhan JF, Solomon J, Mackenzie CD, Geary TG. Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi. Proc Natl Acad Sci U S A. 2010;107(46):20120–5.

Noodin R. Editorial: Lymphatic Filariasis and The Global Elimination. Malaysian J Med Sci. 2007;14(1):1–3.

Allen T, Taleo F, Graves PM, Wood P, Taleo G, Baker MC, et al. Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in. Trop Med Health. 2017;45(8):1–11.

Cantey PT, Rout J, Rou G, Williamson J, Fox LM. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. PLoS Negl Trop Dis. 2010;4(6):e728.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


____________________________________________________________________________________________________________________

JHECDs: Journal of Health Epidemiology and Communicable Diseases

p-ISSN: 2502-0447

e-ISSN: 2503-5134

Published by: Balai Litbang P2B2 Tanah Bumbu, Kementerian Kesehatan RI


JHECDs Indexed by:

google scholar Crossref base ipi neliti

 

Creative Commons License

Visitor Number :

Web
Analytics Made Easy - StatCounter

View our stats
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.